Terms: = Breast cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Clinical Outcome
1 results:
1. Genomic alterations associated with HER2+ breast cancer risk and clinical outcome in response to trastuzumab.
Singla H; Kaur RP; Shafi G; Vashistha R; Banipal RPS; Kumar V; Munshi A
Mol Biol Rep; 2019 Feb; 46(1):823-831. PubMed ID: 30535550
[TBL] [Abstract] [Full Text] [Related]
